What Insulet’s EVOLUTION 2 data means for automated insulin delivery in type 2 diabetes
Insulet's EVOLUTION 2 study shows 68% TIR with no boluses in type 2 diabetes. Analysis of what the FCL data means before the EVOLVE pivotal trial.
Insulet's EVOLUTION 2 study shows 68% TIR with no boluses in type 2 diabetes. Analysis of what the FCL data means before the EVOLVE pivotal trial.
Could IRX4204 help prevent triple-negative breast cancer? Discover what new RXR agonist research could mean for the future of breast cancer prevention.
FDA clears Toro Neurovascular’s Toro 88 catheter for stroke intervention. Discover how this device could reshape neurovascular access and aspiration thrombectomy.
KARL STORZ wins FDA clearance for the FIVE S 6.5 bronchoscope. Discover what this means for ICU airway management and disposable bronchoscopy trends.
QIAGEN wins FDA clearance for GI panels on QIAstat-Dx Rise. Discover what this means for syndromic testing platforms and molecular diagnostics adoption.
Medtronic plans to acquire Scientia Vascular for $550M. Explore what the deal changes for stroke intervention devices and neurovascular procedure access.
QT Imaging wins FDA clearance for an upgraded Breast Acoustic CT scanner. Discover what this means for radiation-free breast imaging.
BD secures EU CE Mark for the Revello vascular covered stent for iliac artery disease. Explore what this device could change for PAD treatment in Europe.
Lohman Technologies and Salvo Health expand their partnership to deploy HomECG+ monitoring in GI care. Discover why HRV data may reshape digital chronic care.
Ultrasound AI wins FDA De Novo clearance for Delivery Date AI. Discover how predictive ultrasound analytics could change prenatal care and delivery timing.